Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH

RecruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

November 20, 2024

Primary Completion Date

November 20, 2043

Study Completion Date

November 20, 2044

Conditions

Metabolic Dysfunction-Associated Steatotic Liver DiseaseHepatocellular CarcinomaMetabolic Dysfunction-Associated SteatohepatitisLiver Transplant

Trial Locations (1)

RECRUITING

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

All Listed Sponsors

lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER